3-(2-[5-Fluoro-1-(4-morpholin-4-yl-butyl)-1H-indol-3-yl]-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridine hydrobromide

ID: ALA5179292

PubChem CID: 168272266

Max Phase: Preclinical

Molecular Formula: C26H27BrFN5OS

Molecular Weight: 475.59

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Br.Fc1ccc2c(c1)c(-c1nc(-c3c[nH]c4ncccc34)cs1)cn2CCCCN1CCOCC1

Standard InChI:  InChI=1S/C26H26FN5OS.BrH/c27-18-5-6-24-20(14-18)22(16-32(24)9-2-1-8-31-10-12-33-13-11-31)26-30-23(17-34-26)21-15-29-25-19(21)4-3-7-28-25;/h3-7,14-17H,1-2,8-13H2,(H,28,29);1H

Standard InChI Key:  OFXKPOFBKPYJJU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    1.7189   -3.0969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9119   -2.9255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3598   -3.5386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4467   -3.3671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7018   -2.5826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2169   -1.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7018   -1.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4862   -1.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2005   -1.0904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9148   -1.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6294   -1.0904    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9148   -2.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2005   -2.7401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4862   -2.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4467   -0.4635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3374   -0.2088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3374    0.6160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0047    1.1008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0047    1.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3941    2.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5653    3.2834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3453    3.5386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9612    2.9908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7892    2.1805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2740    1.5133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7892    0.8459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4467    0.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9317    0.2036    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2708   -2.4839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0158   -1.6995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5676   -1.0865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3744   -1.2579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6294   -2.0423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0776   -2.6553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1197   -0.0899    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  5  6  1  0
  7  6  2  0
  8  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14  8  2  0
 14  5  1  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 19 18  1  0
 19 20  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 24 23  1  0
 19 24  2  0
 24 25  1  0
 26 25  1  0
 18 26  2  0
 27 17  2  0
 27 28  1  0
 15 28  1  0
  1 29  1  0
 30 29  1  0
 31 30  1  0
 32 31  1  0
 33 32  1  0
 34 33  1  0
 29 34  1  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SAOS-2 (672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLS Tchem Glutaminase kidney isoform, mitochondrial (16997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLS2 Tchem Glutaminase liver isoform, mitochondrial (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.59Molecular Weight (Monoisotopic): 475.1842AlogP: 5.56#Rotatable Bonds: 7
Polar Surface Area: 58.97Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.87CX Basic pKa: 7.68CX LogP: 4.78CX LogD: 4.32
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.31Np Likeness Score: -1.90

References

1. Carbone D, Vestuto V, Ferraro MR, Ciaglia T, Pecoraro C, Sommella E, Cascioferro S, Salviati E, Novi S, Tecce MF, Amodio G, Iraci N, Cirrincione G, Campiglia P, Diana P, Bertamino A, Parrino B, Ostacolo C..  (2022)  Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.,  234  [PMID:35286926] [10.1016/j.ejmech.2022.114233]

Source